A comparative study of efficacy and side effects of nifedipine with nifedipine along with dydrogesterone in management of preterm labor [PDF]
Background: Preterm labor remains one of the major cause of neonatal morbidity and mortality. Different tocolytics have been studied for prolongation of pregnancy, role of progesterone in increasing latency period remains controversial.
Anand, Deepak+4 more
core +2 more sources
Dydrogesterone after 60 years: a glance at the safety profile [PDF]
To provide an evidence-based safety and tolerability overview of dydrogesterone under various progesterone-deficient conditions as a commemoration of its role in managing women’s reproductive health over the past 60 years. To identify relevant publications, we used a semi-systematic approach, which included performing a structured search through the ...
Johannes, Ott+2 more
openaire +2 more sources
The Addition of Dydrogesterone after Frozen Embryo Transfer in Hormonal Substituted Cycles with Low Progesterone Levels [PDF]
Objective To determine whether a rescue strategy using dydrogesterone (DYD) could improve the outcomes of frozen embryo transfer cycles (FET) with low progesterone (P4) levels on the day of a blastocyst transfer.
Jose Metello+3 more
doaj +1 more source
Oral dydrogesterone versus oral micronized progesterone in threatened miscarriage: protocol paper for a randomized controlled trial. [PDF]
Kriplani A+9 more
europepmc +2 more sources
Purpose To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real‐world setting. Methods The post‐marketing study involved 15 sites in Japan.
Jo Kitawaki+3 more
doaj +1 more source
Background: The aim of this study was to evaluate the effect of dydrogesterone in the outcome of idiopathic intrauterine growth restriction (IUGR). Materials and Methods: It is a double-blind randomized control clinical trial study that was done in ...
Elaheh Zarean+2 more
doaj +1 more source
A 31-year-old woman with complete androgen insensitivity syndrome (CAIS) experienced breast volume fluctuations during biphasic hormone replacement therapy consisting of estradiol and cyclical dydrogesterone, a progestin.
Benthe A M Dijkman+3 more
doaj +1 more source
Process optimizations for the synthesis of an intermediate of dydrogesterone. [PDF]
Wang Z+7 more
europepmc +2 more sources
Reproductive function and pregnancy outcomes in women treated for idiopathic hyperprolactinemia: A non-randomized controlled study [PDF]
Background: Few studies have focused to determine the peculiarities of the course of pregnancy and pregnancy outcomes after treatment in women with idiopathic hyperprolactinemia.
Kristesashvili, Jenaro+2 more
core +3 more sources
A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial [PDF]
BACKGROUND: Miscarriage is a common complication of pregnancy occurring in 15-20 % of all clinically recognized pregnancies. Currently, there is still no good scientific evidence to support the routine use of progestogens for the treatment of ...
Chan, MKD+5 more
core +1 more source